159 related articles for article (PubMed ID: 3963840)
1. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
2. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
3. Aclacinomycin inhibits suppressor cells in vivo and in vitro.
Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
Behring Inst Mitt; 1984 May; (74):258-61. PubMed ID: 6236791
[TBL] [Abstract][Full Text] [Related]
4. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
5. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
Li ZR; Feng JB; Han R; Yin MB; Xia LJ
Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
[No Abstract] [Full Text] [Related]
6. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
Li ZR; Feng JB; Liang F; Zeng SX; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
[No Abstract] [Full Text] [Related]
7. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
8. [Spergualin, a new antitumor antibiotic].
Takeuchi T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
[TBL] [Abstract][Full Text] [Related]
9. Spergualin: a new antitumour antibiotic.
Umezawa K; Takeuchi T
Biomed Pharmacother; 1987; 41(5):227-32. PubMed ID: 3499181
[TBL] [Abstract][Full Text] [Related]
10. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
11. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Inui T
J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
[No Abstract] [Full Text] [Related]
12. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
13. Mazethramycin, a new member of anthramycin group antibiotics.
Kunimoto S; Masuda T; Kanbayashi N; Hamada M; Naganawa H; Miyamoto M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Jun; 33(6):665-7. PubMed ID: 7419478
[No Abstract] [Full Text] [Related]
14. [Antitumor activity of macromomycin].
Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
[TBL] [Abstract][Full Text] [Related]
15. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
17. Experimental pharmacology of auromomycin in L1210 tumor cells in vitro and in vivo.
Samy TS; Siegel PJ; Hopper WE; Krishan A
Cancer Res; 1984 Aug; 44(8):3202-7. PubMed ID: 6589039
[TBL] [Abstract][Full Text] [Related]
18. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
[No Abstract] [Full Text] [Related]
19. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
20. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
